PhaseRx, Inc. (PZRXQ)
Develops mRNA treatments that enable cells to produce missing liver enzymes.
$0.00+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+0.0%
The outlook
PZRXQ is trading at its 52-week low with minimal price movement today. The stock sits above both its 50- and 200-day moving averages, suggesting some near-term support, though analyst coverage appears thin. The neutral score reflects mixed signals with limited momentum data.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$1,169
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—